Abstract
Granulosa cells (GCs) are the main supporting cells for follicles, and histone acetylation has been reported to regulate follicular development. However, the mechanism of histone acetylation regulating follicular development is still unclear in GCs. In this study, we found that FGA, fibrinogen alpha chain, mediated the survival and fate of GCs. Knockdowns of HDAC1 and HDAC3 significantly inhibited the mRNA level of FGA, while knockdown of HDAC2 notably decreased the protein level of FGA. Moreover, knockdown of HDAC2 repressed the chromatin accessibility and the enrichment level of H3K9ac at -1350/-1454 bp of FGA. In addition, FGA promoted GCs proliferation and cycle progression by up-regulating the expressions of PCNA and CCNE1, whereas it inhibited apoptosis by suppressing the expression of Caspase3. In vitro, FGA was likely to promote follicular development of pigs. In mice, FGA inhibited the apoptosis of GCs and increased the number of corpora lutea, as a result, elevating estradiol levels and advancing the day of pubertal initiation. Both in vitro and in vivo experiments, FGA promoted follicular development by up-regulating PCNA and CCNE1, while inhibited follicular apoptosis by down-regulating Caspase3 and Caspase9. Overall, knockdown of HDAC2 repressed transcription by reducing chromatin accessibility and decreasing H3K9ac binding at the FGA promoter. FGA inhibited apoptosis of GCs by suppressing the expression of Caspase3 and promoted follicular development. This study showed that FGA is a novel target for histone acetylation to regulate follicular development in mammals.
The Role of Histone Acetylation in Ovarian Health
In mammals, the health of ovarian follicles—and thus fertility—depends heavily on the survival of granulosa cells (GCs). When too many GCs undergo apoptosis (programmed cell death), it leads to follicular atresia and ovulatory dysfunction. While scientists knew that histone acetylation (an epigenetic "volume knob" for genes) plays a role in follicular development, the specific molecular targets were unclear.
This research investigates how histone deacetylases (HDACs) regulate GC fate and identifies FGA—a protein traditionally associated with blood clotting—as a surprising and vital survival factor in the ovary. Beyond its well-known role in blood coagulation, FGA acts as a potent anti-apoptotic signal in the ovary by physically binding to Caspase3, effectively "handcuffing" one of the primary executioners of cell death.
Experimental Design and Methodology
The study employed a multi-level experimental approach spanning cell lines, primary tissues, and live animals:
- Cell Models: Human ovarian granulosa cells (KGN line) were used for mechanistic studies involving siRNA knockdowns and plasmid overexpressions.
- Ex Vivo Follicle Culture: Ovarian follicles from pigs (3–5 mm) were isolated and treated with lentiviral vectors to observe real-time growth and apoptosis.
- In Vivo Mouse Studies: Three-week-old C57BL/6 J mice received intraovarian lentiviral injections to assess the impact of FGA on puberty initiation, estradiol (E2) levels, and ovarian morphology.
- Molecular Deep-Dive: The researchers used ChIP-qPCR and chromatin accessibility assays to map H3K9ac binding at the FGA promoter, and Co-Immunoprecipitation (Co-IP) to confirm FGA's physical interaction with apoptotic proteins.
Results: FGA as a Downstream Target of HDAC2
The study pinpointed HDAC2 (rather than HDAC1 or 3) as the primary regulator of FGA. Interestingly, the use of Trichostatin A (TSA), a general HDAC inhibitor, revealed significant changes in the expression of FGA and associated epigenetic markers. Knocking down HDAC2 or inhibiting HDACs with TSA reduced FGA protein levels and altered chromatin accessibility at a specific region of the FGA promoter (-1350/-1454 bp), effectively silencing the gene.
Furthermore, the reduction of FGA through HDAC inhibition led to a dramatic increase in the expression of pro-apoptotic markers. As shown in the mRNA profiles, TSA treatment significantly up-regulated executioner caspases and other cell death regulators like P53 and BIM.
Physiological Impact on Follicular Growth and Puberty
FGA's influence extends beyond preventing cell death; it actively promotes proliferation by up-regulating markers like PCNA and CCNE1, pushing GCs through the cell cycle faster.
Key findings from animal models include:
- Follicular Growth: In porcine follicles, FGA overexpression significantly increased follicle size over five days, while knockdown stunted growth.
- Hormonal Changes: Mice treated with FGA-overexpressing lentiviruses showed elevated serum estradiol (E2) and an increased number of corpora lutea, indicating higher rates of successful ovulation.
- Developmental Timing: Overexpressing FGA in mice advanced the day of pubertal initiation, demonstrating that this single molecular target has whole-organism effects on reproductive timing.
Conclusion and Future Directions
This study identifies FGA as a critical, novel target of the HDAC2/H3K9ac axis that prevents cell death in ovarian follicles. While the paper establishes that FGA binds to Caspase3, the exact structural nature of this binding and its potential interaction with other signaling pathways (like PI3K/Akt) requires further investigation.
Future work may utilize CRISPR-dCas9 systems for more precise epigenetic editing to overcome tissue-specific interference observed in some models. Ultimately, FGA represents a promising therapeutic target for addressing infertility or premature ovarian insufficiency in clinical settings.
Summary updated